The antioxidant activities of resveratrol in cancer therapy are also related to manipulating the expression of NRF2 and its target genes, such as NQO1, SOD3, and 8-oxoguanine DNA glycosylase 1 (OGG1) [109,110], thus inhibiting estrogen-mediated DNA damage and suppressing mammary carcinogenesis [111]. Here, NFE2L2 is linked to cancer.